- This event has passed.
Pharma engagement with HCPs & Patients during and after the COVID-19 crisis – adapting to the “new normal”
The pharma industry faces significant environmentally driven transformation to its commercial operating model during the COVID-19 crisis. How will this play out and what will partnerships and collaboration look like as we recover and thrive post COVID-19?
In this FREE webinar we hear from Sam Pygall at MSD who presents the industry perspective, we find out what HCPs think about the current channel shift and we explore some of the ways in which patient engagement has changed. Will this be the “new normal”?
Tickets for this event are free of charge, if you would like to make a small donation to the PM Society’s charity, PAPYRUS, this would be gratefully received.
To read more about PAPYRUS, the work they do and to make a donation, please visit our charity page.
Please note, If you do not already have a PM Society account, you will need to create a free account in order to register for this event, please click here. If you already have a username and password, you do not need to create a free account. Please contact Alex if you need any assistance.
Please select the number of tickets and complete the fields below before confirming your RSVP.
You will receive an email with details on how to join the Zoom webinar nearer to the event date.
If you have any questions please contact Alex Hankinson
Carwyn Jones, Senior Partner, OPEN Health & Director, PM Society
The Industry perspective – mega trends
Dr Samuel Pygall, Head of Strategy and Business Transformation Office Leader, MSD UK
An individual perspective on the mega trends facing Pharma and the possible impacts on
- Channel shift
- Content shift
- Objective shift
HCPs & the COVID-19 Channel Shift
Neil Reynolds, medeConnect Healthcare Insight
Results from a recent survey on HCP attitudes to the channel shift; how they are engaging online and what they think will happen post COVID-19
Patient Programmes and Patient Support
Richard Jones, OPEN Health
Mark Duman, Global Patient Engagement Thought Leader
How is life changing during this period of uncertainty for patients and how is pharma engaging with them?
- Dr Samuel Pygall, Head of Strategy and Business Transformation Office Leader, MSD UK
- Neil Reynolds, medeConnect Healthcare Insight
- Richard Jones, OPEN Health
- Mark Duman, Global Patient Engagement Thought Leader